← backEmail & CRMFounding · Free forever

Segment audience and write personalized variants

Change subject + opener + CTA only — deeper edits dilute measurability.

by @whitney · recommended tool Claude · 0 unlocks

0

EXAMPLES · WHAT THIS PROMPT PRODUCES

Sample output
**Variant A — Free-trial users (day 7, no upgrade)**
Subject: You've built 3 dashboards. Here's what Pro unlocks.
Opener: You're clearly getting value from Loomi — three dashboards in a week is no accident. The catch? Free caps you at 3, and you're at the wall.
CTA: Unlock unlimited dashboards →
*Targeting logic: They've already demonstrated activation, so we lead with their own usage as proof and frame the cap as the only barrier.*

**Variant B — Lapsed paid users (cancelled 30–90 days ago)**
Subject: We shipped the thing you asked for, Marcus.
Opener: When you left, the #1 reason in your exit survey was slow CSV exports. That's now instant — and it's the reason we're reaching back out.
CTA: Reactivate and see the new exports →
*Targeting logic: Win-back hinges on addressing the stated reason for churn; naming it directly signals we listened.*

**Variant C — Agency/team accounts (5+ seats)**
Subject: Roll Loomi out to your whole team this quarter.
Opener: Your team is sharing one login — we both know that's a workaround. Team plan gives every analyst their own seat and shared workspaces.
CTA: Talk to our team specialist →
*Targeting logic: Multi-seat accounts care about governance and scale, not features; we sell the org-level outcome and route to sales.*

Core offer (20% off annual) held identical across all three.
PRICE HISTORY0 cr · current

PROMPT TEMPLATE · v1.0.0

Given this base email, write 3 personalized variants.
Base: <PASTE>. Segments: <SEG_A>, <SEG_B>, <SEG_C>.
Per variant: rewrite subject, opener, CTA — keep core offer identical.
Explain the targeting logic for each.

RESULTS · WHAT PEOPLE GOT

0
Sign in to show colleagues what this case produced.
No results posted yet. Used this case? Show colleagues what it produced.

DISCUSSION

0 comments
Sign in to join the conversation.
No comments yet — be the first.

MORE LIKE THIS